NO20013529L - Modulation of immune response with ribavirin - Google Patents

Modulation of immune response with ribavirin

Info

Publication number
NO20013529L
NO20013529L NO20013529A NO20013529A NO20013529L NO 20013529 L NO20013529 L NO 20013529L NO 20013529 A NO20013529 A NO 20013529A NO 20013529 A NO20013529 A NO 20013529A NO 20013529 L NO20013529 L NO 20013529L
Authority
NO
Norway
Prior art keywords
ribavirin
modulation
immune response
immune
response
Prior art date
Application number
NO20013529A
Other languages
Norwegian (no)
Other versions
NO20013529D0 (en
Inventor
Robert Tam
Original Assignee
Icn Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals
Publication of NO20013529D0 publication Critical patent/NO20013529D0/en
Publication of NO20013529L publication Critical patent/NO20013529L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
NO20013529A 1999-01-29 2001-07-17 Modulation of immune response with ribavirin NO20013529L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24136799A 1999-01-29 1999-01-29
PCT/US1999/030490 WO2000044388A1 (en) 1999-01-29 1999-12-20 Modulation of immune response by ribavirin

Publications (2)

Publication Number Publication Date
NO20013529D0 NO20013529D0 (en) 2001-07-17
NO20013529L true NO20013529L (en) 2001-09-12

Family

ID=22910442

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013529A NO20013529L (en) 1999-01-29 2001-07-17 Modulation of immune response with ribavirin

Country Status (20)

Country Link
EP (1) EP1146883A4 (en)
JP (1) JP2002535371A (en)
KR (1) KR20020023939A (en)
CN (1) CN1334736A (en)
AU (1) AU2483300A (en)
BR (1) BR9917090A (en)
CA (1) CA2357735A1 (en)
CZ (1) CZ20012519A3 (en)
HK (1) HK1040937A1 (en)
HR (1) HRP20010496A2 (en)
HU (1) HUP0200027A2 (en)
IL (1) IL144130A0 (en)
MX (1) MXPA01007211A (en)
NO (1) NO20013529L (en)
PL (1) PL364699A1 (en)
RU (1) RU2211698C2 (en)
SI (1) SI20802A (en)
SK (1) SK10092001A3 (en)
WO (1) WO2000044388A1 (en)
ZA (1) ZA200105595B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960569B2 (en) 2000-08-17 2005-11-01 Tripep Ab Hepatitis C virus non-structural NS3/4A fusion gene
US6858590B2 (en) 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
SE0950633L (en) * 2006-03-14 2009-09-03 Wholesome Biopharm Pty Ltd Method and composition for the treatment of allergic diseases
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
EP0038629A1 (en) * 1980-04-17 1981-10-28 Beecham Group Plc Virazole derivatives, process for their preparation and use as antiviral agents
BE902199A (en) * 1984-10-29 1985-07-31 Vira Tek Inc METHOD OF MEDICAL TREATMENT OF VIRAL DISEASES USING 1-BETA-D-RIBOFURANNOSYL-1, 2,4-TRIAZOLE-3-CARBOXAMIDE.
AU5668886A (en) * 1986-03-27 1987-10-20 Harry Edward Gruber A method of increasing adenosine excretion
US5030623A (en) * 1986-03-27 1991-07-09 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells
US5767097A (en) * 1996-01-23 1998-06-16 Icn Pharmaceuticals, Inc. Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
BR9707154A (en) * 1996-01-23 1999-05-25 Icn Pharmaceuticals Modulation of cytokine expression in th1 / th2 by ribavirin and ribavirin analogues in activated lymphocytes
CA2267279A1 (en) * 1996-10-16 1998-04-23 Devron Averett Monocyclic l-nucleosides, analogs and uses thereof

Also Published As

Publication number Publication date
EP1146883A4 (en) 2004-11-24
KR20020023939A (en) 2002-03-29
HK1040937A1 (en) 2002-06-28
SI20802A (en) 2002-08-31
AU2483300A (en) 2000-08-18
CZ20012519A3 (en) 2002-05-15
BR9917090A (en) 2001-10-16
SK10092001A3 (en) 2002-02-05
IL144130A0 (en) 2002-05-23
NO20013529D0 (en) 2001-07-17
CN1334736A (en) 2002-02-06
ZA200105595B (en) 2002-10-07
HUP0200027A2 (en) 2002-04-29
HRP20010496A2 (en) 2003-08-31
PL364699A1 (en) 2004-12-13
CA2357735A1 (en) 2000-08-03
MXPA01007211A (en) 2002-05-06
EP1146883A1 (en) 2001-10-24
WO2000044388A1 (en) 2000-08-03
RU2211698C2 (en) 2003-09-10
JP2002535371A (en) 2002-10-22

Similar Documents

Publication Publication Date Title
DE60019197D1 (en) System with speed synchronization of fans
DE69908417D1 (en) HEAT RESINSTICKABLE ADHESIVE COMPOSITION AND ADHESIVE STRUCTURE
DK1218096T3 (en) Variable release microcapsules
NO20015505D0 (en) Preparation of complex carbohydrates
NO20013529D0 (en) Modulation of immune response with ribavirin
NO20016151D0 (en) Preparation of substituted piperidin-4-ones
DE60032898D1 (en) ARYLTHIAZOLIDEINDION AND ARYLOXAZOLIDINE DERIVATIVES
FI980222A0 (en) Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
ID27835A (en) ELECTROMAGNITING PLANNING AND CIRCUIT TO MOVE ELECTROMAGNITING PLANNING
PT1178984E (en) DERIVATIVES OF 1-TRIFLUOROMETHYL-4-HYDROXY-7-PIPERIDINYLAMIMOME
DE60041878D1 (en) PCM MODEM WITH PRE-CODING AND PRESENCING
DE60035089D1 (en) Connecting and carrier element
NO20021260D0 (en) Estimation of amplitude spectra
DE29900419U1 (en) Walker
NO20014845D0 (en) Use of arylalkanoylpyridazines
DE60025033D1 (en) HOB
NO992607D0 (en) System with special effect
DE29900121U1 (en) Stove
PT1232141E (en) ETERIES OF O-DESMETIL-VENLAFAXIN
NO20021234L (en) Use of thienopyrimidines
DE29905542U1 (en) Stove
FIU990032U0 (en) Pair of fasteners
SE9902239D0 (en) Kornisch consisting of several parts
FI980433A0 (en) Foerfarande Foer utnyttjande i samband med tillslutandet av en vaetskefoerpackning
FI980484A0 (en) Foerfarande Foer blaeddring av hypertextssidor med en mobilteleapparat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application